Seagen - Research to reality: Going further for patients with HER2+ metastatic breast cancer Industry Satellite Symposia

What’s available for patients after progression on T-DM1? (ID 360)

Lecture Time
17:37 - 17:47
Speakers
  • O. Tredan (Lyon, France)
Room
Channel 2
Date
Thu, 06.05.2021
Time
17:30 - 18:30